⌕

Alnylam Pharmaceuticals (ALNY) vs Insmed (INSM)

Your goal
● Balanced style: every factor counts equally.
#1 FIT · LEADS
45
Insmed Inc
$121.16 · $27B · as of last close
Best returns
of the stocks compared here

The front-runner. Leads the balanced score. Its widest win over the field is total return.

#2 FIT
43
Alnylam Pharmaceuticals Inc
$165.04 · $22B · as of last close
Highest qualityFastest growerCalmest ride
of the stocks compared here

The challenger. Trails the leader on the balanced score. Its widest win over the field is profitability & quality.

INSM barely leads (45/100 vs ALNY 43) under a balanced style, mostly on total return. But ALNY wins on profitability & quality, so the comparison turns on what you weight. Switch your goal above and watch the scores move.

THE SCORECARD · FACTOR BY FACTOR · the best value in each row is ticked, and a tie ticks every tied column · weight bar shows how much it counts for your goal

FactorALNYINSM
Overall fit score
weighted for your balanced goal
43
✓ 45
7 of 8 factors known
Valuation
Cheaper for what you get
1×
✓ P/E 71 · EV/EBITDA 36.3
P/E fiscal 2025
16
P/E —
5
Growth
Revenue & earnings momentum
1×
✓ —
75
—
46
Profitability & quality
Margins & return on capital
1×
✓ Net 8% · ROIC 27%
fiscal 2025
71
Net −40% · ROIC −44%
TTM through Sep 30, 2026
38
Total return
Share-price change with dividends reinvested
1×
5Y −2%/yr
42
✓ 5Y +29%/yr
90
Risk (calm = better)
Volatility & drawdown
1×
✓ β 0.7 · DD −69%
59
β 0.7 · DD −57%
56
Balance sheet†
Debt vs cash cushion
1×
✓ Net debt/EBITDA −3.4×
fiscal 2025
44
Current ratio 2.86
Sep 30, 2026 balance sheet
42
Dividend & income
Cash paid to you
1×
✓ —
40
✓ —
40
Analyst sentiment
Forward EPS growth (consensus)
1×
✓ Est EPS −51%/yr · 16 analysts
0
no forward consensus
—
† Balance sheet is scored on 5 peer percentiles (current ratio, quick ratio, net debt/EBITDA, interest coverage and debt/equity). The cell shows one of them, so a column can lead on the printed number and still lose the row.
Loading chart…
WHERE EACH ONE IS STRONG
GrowthValueQualityReturnSafetyIncome
■ ALNY■ INSM
CAN YOU STOMACH THE RIDE?
Worst drawdown3-year beta vs S&P 500VolatilityHistory
ALNY−69%0.7552%5Y
INSM−57%0.7274%5Y
Drawdown and volatility are measured over five years on the same total return as the chart, dividends reinvested.
THE CASE FOR & AGAINST EACH
BULL CASE

▲ Leads on profitability & quality: Net 8% · ROIC 27% (score 71).

▲ Leads on growth: — (score 75).

BEAR CASE

▼ Weakest on total return: 5Y −2%/yr (score 42).

BULL CASE

▲ Leads on total return: 5Y +29%/yr (score 90).

BEAR CASE

▼ Weakest on profitability & quality: Net −40% · ROIC −44% (score 38).

▼ Weakest on growth: — (score 46).

WHAT COULD CHANGE THE SCORE
Analyst sentimentCurrently 0/100 (Est EPS −51%/yr · 16 analysts). Taking it to 100 would lift the balanced score by 13 points, the biggest single move available.
ValuationCurrently 16/100 (P/E 71 · EV/EBITDA 36.3). Taking it to 100 would lift the balanced score by 11 points, the next biggest.
ValuationCurrently 5/100 (P/E —). Taking it to 100 would lift the balanced score by 14 points, the biggest single move available.
Profitability & qualityCurrently 38/100 (Net −40% · ROIC −44%). Taking it to 100 would lift the balanced score by 9 points, the next biggest.
Scores are Tenet composites, 0–100, reweighted for your selected goal. Seven of the eight factors are sector percentiles; analyst sentiment is an absolute curve on forward EPS growth, capped at 100, so two very high-growth names can share the top score. Moat/durability is not scored (qualitative, not measurable). Comparison is decision-support, not a recommendation · past performance does not predict future returns · Not investment advice · prices are each company's own latest close, the newest here being Nov 13, 2026 · valuation, growth, quality and balance scores from the Nov 13, 2026 scoring run · analyst consensus, return, risk and income scores computed Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.